Independent Effects of High-cholesterol (High-egg) and High-saturated Fat Diets on LDL-cholesterol
1 other identifier
interventional
77
1 country
1
Brief Summary
This study will comprise a randomized controlled, counter-balanced, cross-over trial to evaluate the independent effects of a high cholesterol (high egg), low saturated fat diet and a high saturated fat, low cholesterol diet on blood lipids. Evaluations also include analysis of physical activity as there is emerging evidence that the lutein and zeaxanthin in egg yolk may increase physical activity levels by crossing the blood-brain barrier and altering neuronal function. The study will also investigate effects on a number of novel lipoprotein parameters (particle size and particle concentrations).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2022
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedFirst Posted
Study publicly available on registry
March 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedDecember 13, 2023
March 1, 2022
1.4 years
February 2, 2022
December 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Low-density lipoprotein cholesterol (LDL-C)
Plasma LDL-C levels (mmol/L)
Baseline
Low-density lipoprotein cholesterol (LDL-C)
Plasma LDL-C levels (mmol/L)
5 weeks
Low-density lipoprotein cholesterol (LDL-C)
Plasma LDL-C levels (mmol/L)
10 weeks
Low-density lipoprotein cholesterol (LDL-C)
Plasma LDL-C levels (mmol/L)
15 weeks
Secondary Outcomes (44)
Blood lipid profiling
Baseline
Blood lipid profiling
5 weeks
Blood lipid profiling
10 weeks
Blood lipid profiling
15 weeks
Fasting glucose
Baseline
- +39 more secondary outcomes
Study Arms (3)
Egg Diet
EXPERIMENTALEgg diet, contains 2 eggs per day and limits saturated fat to 6% of energy intake. Cholesterol intake is 600mg/day. Protein and carbohydrate levels will be maintained at 20% and 40% of energy intake, respectively. This diet will be followed for 5 weeks.
Egg-free Diet
ACTIVE COMPARATOREgg-free diet, limits cholesterol to 300 mg/day (no eggs) with saturated fat intake at 12% of energy intake. Protein and carbohydrate levels will be maintained at 25% and 40% of energy intake, respectively. This diet will be followed for 5 weeks.
Control Diet
ACTIVE COMPARATORComparator diet based on the average Australian diet, limited to 1 egg per week, with saturated fat intake at 12% of energy intake. Cholesterol intake is 600 mg/day. Protein and carbohydrate levels will be maintained at 25% and 40% of energy intake, respectively. This diet will be followed for 5 weeks.
Interventions
30% fat \[6% saturated fat\], 20% protein, 40% carbohydrate, 600 mg cholesterol
30% fat \[12% saturated fat\], 25% protein, 40% carbohydrate, 300 mg cholesterol
30% fat \[12% saturated fat\], 25% protein, 40% carbohydrate, 600 mg cholesterol
Eligibility Criteria
You may qualify if:
- Male or female, aged 18 - 60 years
- Blood LDL-C \<3.5 mmol/L (measured at screening using an automated analyser (Cholestech LDX System).
- Non-smoker (or other nicotine products) (minimum 6 months).
You may not qualify if:
- Have diagnosed cardiovascular disease (including uncontrolled high blood pressure) or a chronic disease, including Type-1 or -2 diabetes, kidney or liver disease, gastrointestinal disorders requiring medical nutrition therapy (e.g., Crohn's disease, irritable bowel, coeliac disease) or any other condition that may have an impact on study outcomes.
- Have allergies or strong aversion to eggs or other components of the test foods (diets are not suitable for vegetarians).
- Consume more than 5 eggs per week in the month prior to beginning the trial.
- Participant has a recent history (within 12 months) or strong potential for alcohol abuse. Defined as \>14 standard drinks per week.
- Have changed medication or supplementation that might affect study outcomes in the last 3 months.
- Take vitamin, mineral, herbal supplementation, or medications that may have an impact on study outcomes.
- Are already involved in another research project within 30 days of commencement of the present study that in the opinion of the investigators will be unsuitable for this study.
- Are pregnant or breastfeeding.
- Show unwillingness to be randomized to either experimental group.
- Failure to satisfy the investigator regarding suitability to participate for any other reason.
- Are unwilling or unable to provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of South Australialead
- American Egg Boardcollaborator
Study Sites (1)
University of South Australia Clinical Trial Facility
Adelaide, South Australia, 5000, Australia
Related Publications (2)
Carter S, Hill AM, Yandell C, Wood L, Coates AM, Buckley JD. Impact of dietary cholesterol from eggs and saturated fat on LDL cholesterol levels: a randomized cross-over study. Am J Clin Nutr. 2025 Jul;122(1):83-91. doi: 10.1016/j.ajcnut.2025.05.001. Epub 2025 May 6.
PMID: 40339906DERIVEDCarter S, Hill AM, Yandell C, Buckley JD, Coates AM. Study protocol for a 15-week randomised controlled trial assessing the independent effects of high-cholesterol and high-saturated fat diets on LDL cholesterol. BMJ Open. 2024 Jan 25;14(1):e081664. doi: 10.1136/bmjopen-2023-081664.
PMID: 38272555DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan D Buckley, PhD
University of South Australia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- It will not be possible to blind participants to the diet being consumed, or the research dietician assisting the participants to comply with the diets. All other research staff involved in data collection will be blinded.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dean of Programs (Human Performance)
Study Record Dates
First Submitted
February 2, 2022
First Posted
March 4, 2022
Study Start
March 1, 2022
Primary Completion
August 10, 2023
Study Completion
August 31, 2023
Last Updated
December 13, 2023
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share